Ticker
DNTHCompany Name
DIANTHUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
---|---|---|---|
6/30/2025 | $ 4.85M | $ 18.78M | 386.88% |
3/31/2025 | $ 6.52M | $ 16.17M | 247.92% |
12/31/2024 | $ 6.24M | $ 12.89M | 206.8% |
9/30/2024 | $ 5.37M | $ 9.7M | 180.81% |
6/30/2024 | $ 4.12M | $ 7.11M | 172.75% |
3/31/2024 | $ 2.25M | $ 4.43M | 196.41% |
12/31/2023 | $ 2.83M | $ 2.9M | 102.62% |
9/30/2023 | $ 924K | $ 3.94M | 426.19% |
6/30/2023 | $ 0 | $ 4.19M | 0% |
3/31/2023 | $ 0 | $ 5.62M | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for DIANTHUS THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 9.67M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ]
Minimum
Dec 31, 2023
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 2.98K |
---|---|
min | -3.97% |
max | 8.43% |
average | 1.72% |
median | 1.04% |
std | 1.9% |